Journal of Dermatology and Dermatologic Surgery (Jan 2020)

Effectiveness of adalimumab in combination with intense pulsed light and radiofrequency therapy (LAight®) for severe hidradenitis suppurativa: A case report

  • Uwe Kirschner,
  • Berenice Maureen Lang,
  • Kerstin Steinbrink,
  • Sophia Zimmer

DOI
https://doi.org/10.4103/jdds.jdds_36_19
Journal volume & issue
Vol. 24, no. 2
pp. 133 – 134

Abstract

Read online

Hidradenitis suppurativa (HS also named as acne inversa) is a chronic skin disease characterized by relapsing formation of abscesses, inflammatory nodules, and fistulas. In moderate-to-severe disease, HS leads to the formation of scarring and thus irreversible tissue destruction. In the past few years, two new treatment options became available: adalimumab, the first biologic therapy approved for HS (Humira®, AbbVie), and a noninvasive, device-based treatment utilizing a combination of intense pulsed light and radiofrequency (LAight® therapy, LENICURA, Germany). Here, we report a case of a Hurley stage III patient where the positive effect of adalimumab could be enhanced by simultaneously applying LAight® therapy. Moreover, long-term symptom control could be achieved under monotherapy with LAight® after adalimumab was terminated.

Keywords